)

CSL's R&D in Switzerland

Innovation is in Our DNA

Investment in R&D is an important driver for CSL’s growth. We continue to build on our capabilities across the R&D value chain, from discovery research to pharmacovigilance to our currently marketed therapies. Such proficiency is critical as R&D builds the novel and diverse pipeline of the future. Learn more by visiting CSL.com.

Our R&D in Switzerland at a Glance

Our Swiss subsidiary was founded in 1949 by the Swiss Red Cross in Bern. Today, we operate as one integrated global research and development organization that assembles coordinated global project teams, drawing together staff from different countries depending on their expertise. To contribute to our global strategic goals, we are strengthening our local R&D network, fully leveraging the opportunities that Switzerland offers as a biotech hotspot while at the same time, allowing for flexible and activity-based ways of working.

  • 500+

    R&D employees in Switzerland

  • 350+

    Scientific papers published with our collaborators since 2015

  • 40+

    Collaborations with academic institutions and hospitals in CH and EU